Epitope cross-reactivity frequently differs between central and effector memory HIV-specific CD8+ T cells

Area of Science:

• Immunology
• Virology
• Vaccinology

Background:

• HIV diversity, marked by epitope sequence variations, poses a significant challenge to developing broad-coverage vaccines.
• Amino acid substitutions in CD8(+) T cell epitopes can impair immune responses, primarily observed in effector T cells.

Purpose of the Study:

• To investigate the differential cross-reactivity of HIV epitope variants in effector versus memory CD8(+) T cell populations.
• To understand how viral diversity is recognized and tolerated by T cells in the context of HIV infection.

Main Methods:

• Analysis of HIV epitope variant cross-reactivity using overnight IFN-gamma assays and longer-term proliferation assays in a Kenyan HIV-infected cohort.
• Assessment of polyfunctionality in proliferating CD8(+) T cells through cytokine analysis.
• Correlation analysis between T cell proliferation/IFN-gamma responses and CD4+ T cell counts.

Main Results:

• Significant differences in HIV epitope variant cross-reactivity were observed between IFN-gamma and proliferation assays.
• Proliferation assays identified preferred recognition of specific variants, often in the absence of detectable IFN-gamma responses or the variant in the viral quasispecies.
• Most proliferating CD8(+) T cells exhibited polyfunctional cytokine production.
• A positive correlation trend was noted between T cell proliferation and CD4+ T cell counts, but not IFN-gamma responses.

Conclusions:

• The distinct recognition patterns of HIV epitope variants in different T cell assays highlight the complexity of immune responses to viral diversity.
• Findings are crucial for evaluating HIV vaccine candidates and understanding T cell tolerance to HIV evolution.
• Proliferation assays may capture a broader spectrum of T cell recognition relevant to vaccine efficacy than IFN-gamma assays alone.